Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Agilent Technologies Inc.. (3/22/23). "Press Release: Agilent Honored with Asia Pacific Bioprocessing Excellence Award 2023 for Analytical Services". Singapore.

Region Region Asia & Oceania (APAC)
Organisations Organisation ProZyme Inc.
  Organisation 2 A*STAR (Agency for Science, Technology and Research)
  Group Singapore (govt)
Product Product biologics manufacturing technology

Agilent Technologies Inc. (NYSE: A) was honored with the Asia Pacific Bioprocessing Excellence Award (ABEA 2023) under the Best Bioprocessing Supplier Award in the Analytical Services category. The awards ceremony was held in conjunction with the 10th annual Biologics Manufacturing Asia 2023 conference in Singapore.

Agilent has seen rapid growth in the bioprocessing space through acquisitions of ProZyme, Advanced Analytical Technologies, and e-MSion to bolster its portfolio with biopharma consumables, separators and mass spectrometer devices. The company’s high-performance liquid chromatography (HPLC) instruments increase accuracy, speed and performance for biotherapeutic and environmental research development.

In Singapore, Agilent collaborates with the Institute of Bioengineering & Bioimaging (IBB), a research institute of Singapore’s Agency for Science, Technology and Research (A*STAR), on new analytical approaches to the efficient translation of mRNA and lipid nanoparticles to improve manufacturing, storage and analytical techniques for mRNA vaccines.

“At Agilent, we pride ourselves on our bioprocessing excellence and expertise, especially in providing researchers with optimizing options to push scientific discoveries,” said Chow Woai Sheng, Singapore general manager and vice president of global instrument manufacturing of Agilent. “To be recognized by the life science community in Asia as the best bioprocessing supplier reflects our commitment to continue delivering high-quality answers in areas of unmet need and improving the quality of life locally and regionally.”

Agilent Singapore was established as its Asia Pacific Regional Center with a 172,000 square foot facility located in Yishun. In 2017, the company announced an SG$85 million investment plan in Singapore comprising manufacturing and research activities to expand over five years. Its Global Solution Development Center was launched a year later to develop integrated end-to-end workflow methods and novel applications for global markets.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that help customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at To receive the latest Agilent news, please subscribe to the Agilent Newsroom.

Follow Agilent on LinkedIn and Facebook.

Media Relations, South Asia Pacific

Grace Thong
Agilent Technologies
+65 9688 2152

Record changed: 2024-01-06


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Agilent (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px

» top